SEC Form D private-offering filing

Terremoto Biosciences, Inc.

Name: Terremoto Biosciences, Inc. - new SEC Form D private-offering filing, South San Francisco, CA
Published: 2026-04-22

A new SEC Form D private-offering notice from South San Francisco, CA, a $108,599,999 filer-stated offering target in Biotech. The source filing is one click away.

Terremoto Biosciences, Inc. site↗ Verified via SEC Form D

Clinical stage biotech developing selective covalent AKT1 inhibitors for oncology and hereditary hemorrhagic telangiectasia; recently closed a $108 million Series C.

Filed 2026-04-22Filed to raise $108,599,999First money in 2026-04-10Raised so far $40,725,000HQ (as filed) South San Francisco, CASector Biotech ✓Stage (inferred) LateCall status Call-ready

Source linked the Form D on EDGAR↗Website verified terremotobio.com↗Named in the filing 7 executives & directors

Open this row on the live feed →More new filings in California →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.